Shopping Cart
- Remove All
- Your shopping cart is currently empty
AChE/BuChE/MAO-B-IN-2 (compound 4b) is a potent inhibitor of AChE, BuChE, and hu MAO-B, with respective IC50 values of 5.3 μM, 12.4 μM, and 1.9±0.08 μM, indicating good in vitro blood-brain barrier (BBB) permeability. It effectively reduces excessive AChE and BuChE levels associated with Alzheimer's disease (AD) and holds potential for anti-Alzheimer's research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | AChE/BuChE/MAO-B-IN-2 (compound 4b) is a potent inhibitor of AChE, BuChE, and hu MAO-B, with respective IC50 values of 5.3 μM, 12.4 μM, and 1.9±0.08 μM, indicating good in vitro blood-brain barrier (BBB) permeability. It effectively reduces excessive AChE and BuChE levels associated with Alzheimer's disease (AD) and holds potential for anti-Alzheimer's research [1]. |
Targets&IC50 | MAO-B (human):1.9 μM, BChE:12.4 μM, AChE:5.3 μM |
In vitro | Compound 4b (AChE/BuChE/MAO-B-IN-2) at concentrations of 5, 10, 20 μmol/L for 2 hours, exhibited significant neuroprotective effects against Aβ1-42-induced damage in PC12 cells [1]. Additionally, when incubated at 1 mg/mL in simulated gastric/intestinal fluid, plasma, and rat liver microsomes, AChE/BuChE/MAO-B-IN-2 demonstrated good stability over time periods of 0, 0.5, 1, 1.5, 2, and 3 hours [1]. |
In vivo | AChE/BuChE/MAO-B-IN-2 (compound 4b), at concentrations of 0.0049, 0.0195, and 0.078 μg/mL with a 10-minute treatment, significantly ameliorated motor dysfunction and improved responsiveness in a zebrafish Alzheimer's disease model induced by ACAL 3 [1]. |
Molecular Weight | 327.35 |
Formula | C19H18FNO3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.